Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE StudyBrian Bressler, Gerassimos J. Mantzaris, Emanuelle Bellaguarda et al.|Journal of Crohn s and Colitis|2021Cited by 148
Effectiveness of dabrafenib in the treatment of patients with BRAF V600–mutated metastatic melanoma in a Named Patient ProgramSalvador Martín‐Algarra, Michael Millward, Rebecca A. Hinshelwood et al.|Melanoma Research|2019Cited by 11